Pregabalin is a prescription anticonvulsant and analgesic agent. As of April 2026, China has officially placed oral single-agent pregabalin formulations under strict regulatory control.
To support law enforcement efforts, AccuSift provides high-performance competitive antibody pairs for pregabalin detection. These reagents offer exceptional inter-batch consistency and are optimized specifically for IVD kit development, including lateral flow assays, chemiluminescence, ELISA, and POCT platforms. Featuring high affinity and high specificity, they enable rapid and reliable detection.